thyssenkrupp nucera AG (THYKF) Fair Value & Analysis
Industrials · US · Market cap $1.5B
Fair value as of: Jun 24, 2026
Analysis
thyssenkrupp nucera AG (THYKF) currently trades at $10.18, while our model-based Fair Value estimate is $7.40 — implying the stock looks roughly 27.3% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
thyssenkrupp nucera AG & Co. KGaA engages in the development, engineering, procurement, commissioning, and licensing of electrolysis technologies in Germany, Saudi Arabia, Sweden, the United States, and internationally. It operates through the Chlor-Alkali (CA) and Green Hydrogen (gH2) segments. The company is involved in the development, planning, and construction of new-build electrolysis plants for producing green hydrogen for industrial applications; provision of services for chlor-alkali electrolysis, such as planning and construction of new plants. It also offers the BM 2.7 single-element technology and BiTAC filter press technology. The company was formerly known as thyssenkrupp Uhde Chlorine Engineers GmbH. The company was founded in 1960 and is headquartered in Dortmund, Germany. thyssenkrupp nucera AG & Co. KGaA operates as a subsidiary of Thyssenkrupp Projekt 1 GmbH.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is thyssenkrupp nucera AG (THYKF) undervalued?
What is the fair value of THYKF?
What is the quality score of THYKF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.